515 related articles for article (PubMed ID: 14557287)
1. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.
De Clercq E
Clin Microbiol Rev; 2003 Oct; 16(4):569-96. PubMed ID: 14557287
[TBL] [Abstract][Full Text] [Related]
2. Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections.
De Clercq E
Expert Rev Anti Infect Ther; 2003 Jun; 1(1):21-43. PubMed ID: 15482100
[TBL] [Abstract][Full Text] [Related]
3. Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections.
De Clercq E
Intervirology; 1997; 40(5-6):295-303. PubMed ID: 9675635
[TBL] [Abstract][Full Text] [Related]
4. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication.
Keith KA; Hitchcock MJ; Lee WA; Holý A; Kern ER
Antimicrob Agents Chemother; 2003 Jul; 47(7):2193-8. PubMed ID: 12821467
[TBL] [Abstract][Full Text] [Related]
6. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.
De Clercq E
Biochem Pharmacol; 2007 Apr; 73(7):911-22. PubMed ID: 17045247
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
De Clercq E
Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
[TBL] [Abstract][Full Text] [Related]
8. The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond.
De Clercq E
Biochem Pharmacol; 2011 Jul; 82(2):99-109. PubMed ID: 21501598
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of the acquired immune deficiency syndrome (AIDS): acyclic nucleoside phosphonate analogues.
De Clercq E
Int J Immunopharmacol; 1991; 13 Suppl 1():91-8. PubMed ID: 1823910
[TBL] [Abstract][Full Text] [Related]
10. A review of topical and intralesional cidofovir.
Zabawski EJ
Dermatol Online J; 2000 Sep; 6(1):3. PubMed ID: 11328613
[TBL] [Abstract][Full Text] [Related]
11. Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients.
Snoeck R; De Clercq E
Curr Opin Investig Drugs; 2002 Nov; 3(11):1561-6. PubMed ID: 12476953
[TBL] [Abstract][Full Text] [Related]
12. The Holý Trinity: the acyclic nucleoside phosphonates.
De Clercq E
Adv Pharmacol; 2013; 67():293-316. PubMed ID: 23886004
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl)adenine, 9-(2-phosphonylmethoxyethyl)guanine, (R)-9-(2-phosphonylmethoxypropyl)adenine, and MDL 74,968] in cell cultures and murine sarcoma virus-infected newborn NMRI mice.
Balzarini J; Vahlenkamp T; Egberink H; Hartmann K; Witvrouw M; Pannecouque C; Casara P; Navé JF; De Clercq E
Antimicrob Agents Chemother; 1997 Mar; 41(3):611-6. PubMed ID: 9056002
[TBL] [Abstract][Full Text] [Related]
14. Antitumor potential of acyclic nucleoside phosphonates.
De Clercq E; Andrei G; Balzarini J; Hatse S; Liekens S; Naesens L; Neyts J; Snoeck R
Nucleosides Nucleotides; 1999; 18(4-5):759-71. PubMed ID: 10432678
[TBL] [Abstract][Full Text] [Related]
15. Cidofovir in the treatment of poxvirus infections.
De Clercq E
Antiviral Res; 2002 Jul; 55(1):1-13. PubMed ID: 12076747
[TBL] [Abstract][Full Text] [Related]
16. The acyclic nucleoside phosphonates from inception to clinical use: historical perspective.
De Clercq E
Antiviral Res; 2007 Jul; 75(1):1-13. PubMed ID: 17116336
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication.
Neyts J; De Clercq E
Biochem Pharmacol; 1994 Jan; 47(1):39-41. PubMed ID: 8311844
[TBL] [Abstract][Full Text] [Related]
18. Cidofovir in the therapy and short-term prophylaxis of poxvirus infections.
De Clercq E
Trends Pharmacol Sci; 2002 Oct; 23(10):456-8. PubMed ID: 12368068
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.
Cundy KC
Clin Pharmacokinet; 1999 Feb; 36(2):127-43. PubMed ID: 10092959
[TBL] [Abstract][Full Text] [Related]
20. Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS.
De Castro LM; Kern ER; De Clercq E; Ghaffar A; Mayer EP; Vogt PE; Gangemi JD
Antiviral Res; 1991 Jul; 16(1):101-14. PubMed ID: 1663726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
